Skip to main content
Top
Published in: BMC Medicine 1/2014

Open Access 01-12-2014 | Commentary

Preventing pre-eclampsia - are dietary factors the key?

Authors: Jodie M Dodd, Cecelia O’Brien, Rosalie M Grivell

Published in: BMC Medicine | Issue 1/2014

Login to get access

Abstract

Pre-eclampsia is a common pregnancy related condition, which contributes significantly both to maternal and perinatal morbidity and mortality. The precise pathophysiology of pre-eclampsia is uncertain, and the development of effective preventive strategies remains elusive.
Schoenaker and colleagues conducted a systematic review and meta-analysis of observational studies reporting dietary intake and dietary patterns. The findings indicated that women with a low dietary calcium intake were more likely to be diagnosed with gestational hypertension, while there was a suggestion (although not statistically significant) of a beneficial effect of a diet rich in fruits and vegetables on risk of pre-eclampsia.
This is in contrast to the findings of systematic reviews and meta-analyses of randomised trials in pregnancy evaluating calcium supplementation and anti-oxidant vitamin C and E supplementation.
The validity of any systematic review is reliant on both the underlying methodology and the quality of each of the included studies; the review by Schoenaker and colleagues is limited by the observational nature of the included studies.
Literature
1.
go back to reference Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet. 2005, 365: 785-799. 10.1016/S0140-6736(05)17987-2.CrossRefPubMed Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet. 2005, 365: 785-799. 10.1016/S0140-6736(05)17987-2.CrossRefPubMed
2.
go back to reference Geographic variation in the incidence of hypertension in pregnancy: World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy.Am J Obstet Gynecol 1988, 158:80-83.. Geographic variation in the incidence of hypertension in pregnancy: World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy.Am J Obstet Gynecol 1988, 158:80-83..
3.
go back to reference Wallis AB, Saftlas AF, Hsia J, Atrash HK: Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008, 21: 521-526. 10.1038/ajh.2008.20.CrossRefPubMed Wallis AB, Saftlas AF, Hsia J, Atrash HK: Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008, 21: 521-526. 10.1038/ajh.2008.20.CrossRefPubMed
4.
go back to reference Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S, Gokhale M, Kotelchuck M, Melve KK, Langridge A, Morris C, Morris JM, Nassar N, Norman JE, Norrie J, Sørensen HT, Walker R, Weir CJ: Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open. 2011, 1: e000101-10.1136/bmjopen-2011-000101.CrossRefPubMedPubMedCentral Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S, Gokhale M, Kotelchuck M, Melve KK, Langridge A, Morris C, Morris JM, Nassar N, Norman JE, Norrie J, Sørensen HT, Walker R, Weir CJ: Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open. 2011, 1: e000101-10.1136/bmjopen-2011-000101.CrossRefPubMedPubMedCentral
5.
go back to reference Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009, 33: 130-137. 10.1053/j.semperi.2009.02.010.CrossRefPubMed Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009, 33: 130-137. 10.1053/j.semperi.2009.02.010.CrossRefPubMed
6.
go back to reference Ronsmans C, Graham WJ: Maternal mortality: who, when, where, and why. Lancet. 2006, 368: 1189-1200. 10.1016/S0140-6736(06)69380-X.CrossRefPubMed Ronsmans C, Graham WJ: Maternal mortality: who, when, where, and why. Lancet. 2006, 368: 1189-1200. 10.1016/S0140-6736(06)69380-X.CrossRefPubMed
7.
go back to reference Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet. 2006, 367: 1066-1074. 10.1016/S0140-6736(06)68397-9.CrossRefPubMed Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet. 2006, 367: 1066-1074. 10.1016/S0140-6736(06)68397-9.CrossRefPubMed
8.
go back to reference The World Health Report 2005: Make Every Mother and Child Count. 2005, WHO, Geneva The World Health Report 2005: Make Every Mother and Child Count. 2005, WHO, Geneva
9.
go back to reference Lewis G: The Confidential Enquiry into Maternal and Child Health (CEMACH): Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: 2007. Lewis G: The Confidential Enquiry into Maternal and Child Health (CEMACH): Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: 2007.
10.
go back to reference Lewis G, Drife JO: Why Mothers Die 2000-2002: The Sixth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: 2004. Lewis G, Drife JO: Why Mothers Die 2000-2002: The Sixth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: 2004.
11.
go back to reference Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002, 359: 1877-1890. 10.1016/S0140-6736(02)08778-0.CrossRefPubMed Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002, 359: 1877-1890. 10.1016/S0140-6736(02)08778-0.CrossRefPubMed
12.
go back to reference National Insitute for Health Care Excellence: Hypertension in Pregnancy: The Management of Hypertensive Disorders during Pregnancy. London: 2010. National Insitute for Health Care Excellence: Hypertension in Pregnancy: The Management of Hypertensive Disorders during Pregnancy. London: 2010.
13.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams DJ: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007, 335: 974-10.1136/bmj.39335.385301.BE.CrossRefPubMedPubMedCentral Bellamy L, Casas JP, Hingorani AD, Williams DJ: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007, 335: 974-10.1136/bmj.39335.385301.BE.CrossRefPubMedPubMedCentral
14.
go back to reference Fisher KA, Lugar A, Spargo BH, Lindeheimer MD: Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine (Baltimore). 1981, 60: 267-276. 10.1097/00005792-198107000-00002.CrossRef Fisher KA, Lugar A, Spargo BH, Lindeheimer MD: Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine (Baltimore). 1981, 60: 267-276. 10.1097/00005792-198107000-00002.CrossRef
15.
go back to reference Laws PJ, Li Z, Sullivan EA: Australia’s Mothers and Babies 2008. Australian Institute of Health and Welfare; 2010. Laws PJ, Li Z, Sullivan EA: Australia’s Mothers and Babies 2008. Australian Institute of Health and Welfare; 2010.
16.
go back to reference Kramer MS, Séguin L, Lydon J, Goulet L: Socio-economic disparities in pregnancy outcome: why do the poor fare so poorly?. Paediatr Perinat Epidemiol. 2000, 14: 194-210. 10.1046/j.1365-3016.2000.00266.x.CrossRefPubMed Kramer MS, Séguin L, Lydon J, Goulet L: Socio-economic disparities in pregnancy outcome: why do the poor fare so poorly?. Paediatr Perinat Epidemiol. 2000, 14: 194-210. 10.1046/j.1365-3016.2000.00266.x.CrossRefPubMed
17.
go back to reference Hewitt BG, Newnham JP: A review of the obstetric and medical complications leading to the delivery of infants of very low birthweight. Med J Aust. 1988, 149: 234.PubMed Hewitt BG, Newnham JP: A review of the obstetric and medical complications leading to the delivery of infants of very low birthweight. Med J Aust. 1988, 149: 234.PubMed
18.
go back to reference Saigal S, Doyle LW: An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008, 371: 261-269. 10.1016/S0140-6736(08)60136-1.CrossRefPubMed Saigal S, Doyle LW: An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008, 371: 261-269. 10.1016/S0140-6736(08)60136-1.CrossRefPubMed
19.
go back to reference Strauss RS: Adult functional outcome of those born small for gestational age. Twenty-six year follow up of the 1970 British Birth Cohort. JAMA. 2000, 283: 625-632. 10.1001/jama.283.5.625.CrossRefPubMed Strauss RS: Adult functional outcome of those born small for gestational age. Twenty-six year follow up of the 1970 British Birth Cohort. JAMA. 2000, 283: 625-632. 10.1001/jama.283.5.625.CrossRefPubMed
20.
go back to reference Barker DJ: Mothers, Babies and Disease in Later Life. 1998, Harcourt Brace & Co, London Barker DJ: Mothers, Babies and Disease in Later Life. 1998, Harcourt Brace & Co, London
22.
go back to reference Duley L, Henderson-Smart DJ, Meher S, King JF: Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007, 2. Duley L, Henderson-Smart DJ, Meher S, King JF: Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007, 2.
23.
go back to reference Hofmeyr GJ, Atallah AN, Duley L: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010, 8. Hofmeyr GJ, Atallah AN, Duley L: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010, 8.
24.
go back to reference Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Catalano P, Hauguel-de Mouzon S: Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig. 2006, 13: 53-57. 10.1016/j.jsgi.2005.10.003.CrossRefPubMed Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Catalano P, Hauguel-de Mouzon S: Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig. 2006, 13: 53-57. 10.1016/j.jsgi.2005.10.003.CrossRefPubMed
25.
go back to reference NHMRC Evidence Hierarchy: designations of `levels of evidence’ for intervention studies. NHMRC levels of evidence and grades for recommendations. 2009 NHMRC Evidence Hierarchy: designations of `levels of evidence’ for intervention studies. NHMRC levels of evidence and grades for recommendations. 2009
26.
go back to reference Cook DA: Randomized controlled trials and meta-analysis in medical education: What role do they play?. Med Teach. 2012, 34: 468-473. 10.3109/0142159X.2012.671978.CrossRefPubMed Cook DA: Randomized controlled trials and meta-analysis in medical education: What role do they play?. Med Teach. 2012, 34: 468-473. 10.3109/0142159X.2012.671978.CrossRefPubMed
Metadata
Title
Preventing pre-eclampsia - are dietary factors the key?
Authors
Jodie M Dodd
Cecelia O’Brien
Rosalie M Grivell
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2014
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-014-0176-4

Other articles of this Issue 1/2014

BMC Medicine 1/2014 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgements for 2013